Professional Documents
Culture Documents
The Immune Regulation and Risk of Allergy: Zakiudin Munasir
The Immune Regulation and Risk of Allergy: Zakiudin Munasir
The Immune Regulation and Risk of Allergy: Zakiudin Munasir
REGULATION
AND RISK OF
ALLERGY
ZAKIUDIN MUNASIR
Outline
Immune system
Immune regulation
• Immune regulation in the gut: A bridge to
systemic immunity
Immune disorders
• Hyperimmune disorders
• Hypoimmune disorders
Carbohydrates: immuno-nutrition
breakthrough
What factors that affect development of optimal immune system in early life?
• In its development, the immune system early in life goes through rapid and radical change.
• Host, environmental and microbial factors, determine the growth and maturation of the peripheral Trends Immunol;
immune system and subsequent immune developments early in life. 2015, 36 (11):684-96
GENETIC FACTOR ENVIRONMENT FACTOR
AGE • Allergens
• Cytokine dysregulation • Infections
• Pollutant
ALLERGIC DISEASES
Gern JE, Lemanske Jr RF. Immunol Allergy North Amer 1999; 19:233-52.
Immune Regulation Utrecht University
Th1/Th2 Paradigm
Resistance to intracellular
infections Resistance to
extracellular infections
Anti-cancer
Tolerance
Delayed type hypersensitivity
reactions
Th1/Th17 Th0 Th2
APC
T-cell mediated autoimmunity
Allergy
Graft rejection Antibody-mediated autoimmunity
Th 1
Th 2
T reg
Natural Imbalance Utrecht University
• Th2 directed immune system: cytokines down regulate cellular-immunity (Th1) > no
rejection of the fetus and or mother tissues
Th 1 Th 2
CD 69+ CD 94+
IL 2 IL 4
TNF α Recurrent Normal IL 5
TNF δ Failure Miscarriages Pregnancies IL 10
After birth
• mite ~ 47 %
• egg, milk ~ 75 %
• less IFN and more IL 4 & 10
IgE at birth
? transplacental protein,
peptide, cytokines
Gut Microbes. 2012; 3(1): 4–14.
IMPACT C-SECTION DELIVERY MODE ON CHILD’S
IMMUNE DEVELOPMENT
Compounds with immunological
properties in human milk Utrecht University
Oligosaccharides
section on
◦ Allergic rhinitis (OR 1.23, 95% CI 1.12–1.35; seven studies)
◦ Asthma (OR 1.18, 95% CI 1.05–1.32; 13 studies)
Allergic ◦ Hospitalization for asthma (OR 1.21, 95% CI 1.12–1.31;
Outcomes
seven studies)